Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Lymphoblastic Leukemia
Study results from University of Tennessee broaden understanding of acute lymphoblastic leukemia
April 20th, 2008
According to a study from the United States, "Background and Purpose Up to 38% of children receiving treatment for acute lymphoblastic leukemia (ALL) develop osteonecrosis, often without symptoms. Little is known about the association between the degree of osteonecrosis and functional mobility in this population." "The purpose of this study was to examine relationships among the degree of osteonecrosis, pain, range of motion (ROM), and functional mobility in people with ALL. Thirty-three subjects aged 5 to 27 years with ALL and osteonecrosis participated. The extent of osteonecrosis was determined by magnetic resonance imaging (MRI) of the hip and knee according to 2...
Source: Pharma Investments, Ventures & Law Weekly (2008-04-20)
|
